Holen Sie sich die Stockscreener-App
0.9799
5.07%
0.0473
Handel nachbörslich:
.97
-0.0099
-1.01%
Opus Genetics Inc Aktie (IRD) Neueste Nachrichten
Opus Genetics to Participate in Upcoming Investor Conference in April - The Manila Times
Exclusive Ophthalmology Gene Therapy Updates: Opus Genetics CEO Takes Center Stage at RBC Conference - Stock Titan
Opus Genetics (NASDAQ:IRD) Receives Buy Rating from HC Wainwright - Defense World
Opus Genetics (NASDAQ:IRD) Price Target Cut to $8.00 by Analysts at Jones Trading - Defense World
Opus Genetics price target lowered to $8 from $9 at JonesResearch - TipRanks
H.C. Wainwright maintains $8 target on Opus Genetics stock By Investing.com - Investing.com South Africa
H.C. Wainwright maintains $8 target on Opus Genetics stock - Investing.com India
Opus Genetics Announces Full Year 2024 Financial Results, Provides Corporate Update - VisionMonday.com
Opus Genetics earnings missed by $1.22, revenue fell short of estimates - Investing.com Canada
Opus Leans Lower on Year-End Figures - Baystreet.ca
Opus Genetics Announces Financial Results for Full Year 2024 - TradingView
Ousted founder of drug development company tries to take back the reins - Crain's Detroit Business
Critical Contrast: Mersana Therapeutics (NASDAQ:MRSN) & Opus Genetics (NASDAQ:IRD) - Defense World
Pleasing Signs As A Number Of Insiders Buy Opus Genetics Stock - simplywall.st
Several Insiders Invested In Opus Genetics Flagging Positive News - Yahoo Finance
Opus Genetics closes $20M offering, issues private placement - Investing.com India
Opus Genetics closes $20M offering, issues private placement By Investing.com - Investing.com South Africa
Opus Genetics founder Mina Sooch files preliminary proxy materials for co board election - MarketScreener
Restore Value Slate Led by Mina Sooch Files Preliminary Proxy Materials for the Election of Six Highly Qualified Directors at the 2025 Annual Meeting of Opus Genetics - The Manila Times
Opus Genetics Prices Public Offering At $0.95/Share, Raising Over $20M - Nasdaq
Opus Genetics announces $21.5 million capital raise - Investing.com
Opus Genetics Prices Public Offering, Private Placement -March 21, 2025 at 09:33 am EDT - MarketScreener
Opus Genetics Announces Presentation on Phentolamine - GlobeNewswire
Opus Genetics announces $21.5 million capital raise By Investing.com - Investing.com Australia
1 Wall Street Analyst Thinks Tesla Will Hit $425. Is it a Buy Around $235? - The Globe and Mail
Opus Genetics, Inc. Announces $20 Million Public Offering and $1.5 Million Private Placement to Fund Clinical Development Initiatives - Nasdaq
Opus Genetics Announces Pricing of Public Offering and - GlobeNewswire
Opus Genetics Secures $21.5M Backing: Perceptive Advisors Leads Gene Therapy Push - Stock Titan
Opus Genetics reports $56.8 million loss for 2024 By Investing.com - Investing.com South Africa
Opus Genetics reports $56.8 million loss for 2024 - Investing.com
Form 424B5 Opus Genetics, Inc. - StreetInsider
Opus Genetics enhances shareholder rights, sues for patent infringement By Investing.com - Investing.com South Africa
Opus Genetics enhances shareholder rights, sues for patent infringement - Investing.com India
Opus Genetics grants stock options to new employees - Investing.com
Opus Genetics Approves Equity Awards for New Employees Under 2021 Inducement Plan - Nasdaq
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Examining the Potential Price Growth of TREX Co., Inc (TREX) - Knox Daily
Opus Genetics Strengthens Team with Strategic Stock Options Package for Key New Hires - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Lumen21 Files Trademark Suit Over Rival's 2020 'Lumen' Rebrand - Bloomberg Law
US Space Force Can Proceed With $2.5 Billion Weapons Procurement - Bloomberg Law
Opus, Viatris Unit Sue Sandoz to Block Copy of Ryzumvi Eye Drug - Bloomberg Law
Disabled Applicant's Open-Book Exam Request Was Lawfully Denied - Bloomberg Law
1 Stock Under $50 with Exciting Potential and 2 to Ignore - The Globe and Mail
Trump Deportation Threats Draw Lawsuit From Cornell Students (1) - Bloomberg Law
Pre-market Movers: HCTI, HEPA, ZYXI, SYRS ... - RTTNews
Pre-market Movers: AWH, TSVT, CUTR, SNOA... - RTTNews
Opus Genetics, Inc. Announces Acceptance of Three Abstracts for Presentation at ARVO 2025 Meeting - Nasdaq
Opus Genetics Announces Presentations at Association for - GlobeNewswire
Can Opus Genetics' Eye Disease Treatments Restore Vision? New Clinical Data Emerges - StockTitan
Opus Genetics faces patent challenge from Sandoz By Investing.com - Investing.com Australia
Opus Genetics faces patent challenge from Sandoz - Investing.com
Opus Genetics In Jan, Got Paragraph IV Certification Notice From Winston & Strawn, Counsel To Sandoz Incorporated - Marketscreener.com
Opus Genetics sets April 30 for 2025 Annual Meeting - MSN
Wells Fargo & Company Has Lowered Expectations for Westlake (NYSE:WLK) Stock Price - Defense World
1.23%
1.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):